🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to evaluate the safety, tolerability, single-a...
Status
Completed
Location
Parexel International
Start Date
2024-07-11
Trial ID
NCT06562114
Treatments Being Tested
This study will assess the safety, tolerability, pharmacokinetics (PK), and...
Status
Completed
Location
Research Site
Start Date
2022-05-18
Trial ID
NCT05384262
This study is the first administration of GSK610677 to man. The main aim of...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05-26
Trial ID
NCT00694902
A study in healthy male and female participants of non-childbearing potenti...
Status
Completed
Location
Research Site
Start Date
2022-09-20
Trial ID
NCT05511025
Treatments Being Tested
A Phase 1 study will test the safety, tolerability and pharmacokinetics of ...
Status
Completed
Location
Nucleus Network Limited
Start Date
2016-07-26
Trial ID
NCT03096756
This is a Phase I, multi-center, double-blind, randomized, placebo-controll...
Status
Completed
Location
Acorda Investigational Site
Start Date
2013-03
Trial ID
NCT01803867
Treatments Being Tested
This study is the first administration of GSK2982772 in humans. The study w...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-01-06
Trial ID
NCT02302404
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and drug...
Status
Recruiting
Location
CenExel ACT (Formerly Anaheim Clinical Trials; LLC)
Start Date
2025-12-23
Trial ID
NCT07283263
Treatments Being Tested